Cystic fibrosis in the mouse by targeted insertional mutagenesis

J R Dorin, P Dickinson, E W Alton, S N Smith, D M Geddes, B J Stevenson, W L Kimber, S Fleming, A R Clarke, M L Hooper

    Research output: Contribution to journalArticle

    228 Citations (Scopus)

    Abstract

    Cystic fibrosis is a fatal genetic disorder which afflicts 50,000 people worldwide. A viable animal model would be invaluable for investigating and combating this disease. The mouse cystic fibrosis transmembrane conductance regulator gene was disrupted in embryonal stem cells using an insertional gene targeting vector. Germ-line chimaeras were derived and the offspring of heterozygous crosses studied. These homozygous mutant mice survive beyond weaning. In vivo electrophysiology demonstrates the predicted defect in chloride ion transport in these mice and can distinguish between each genotype. Histological analysis detects important hallmarks of human disease pathology, including abnormalities of the colon, lung and vas deferens. This insertional mouse mutation provides a valid model system for the development and testing of therapies for cystic fibrosis patients.
    Original languageEnglish
    Pages (from-to)211-5
    Number of pages5
    JournalNature
    Volume359
    Issue number6392
    DOIs
    Publication statusPublished - 1992

    Fingerprint Dive into the research topics of 'Cystic fibrosis in the mouse by targeted insertional mutagenesis'. Together they form a unique fingerprint.

  • Cite this

    Dorin, J. R., Dickinson, P., Alton, E. W., Smith, S. N., Geddes, D. M., Stevenson, B. J., Kimber, W. L., Fleming, S., Clarke, A. R., & Hooper, M. L. (1992). Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature, 359(6392), 211-5. https://doi.org/10.1038/359211a0